Targeting angiosarcomas of the soft tissues: A challenging effort in a heterogeneous and rare disease

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Angiosarcomas are rare malignant tumors with poor prognosis and heterogeneous presentation.
• Consistent molecular characteristics and driver events in angiosarcoma remain challenging to establish.
• Investigated oncogenic and angiogenesis pathways yield varying pre-clinical and clinical results.

Purpose of the Study:

• To review critical biological pathways and processes in angiosarcoma development.
• To explore the potential role of these pathways in novel, non-cytotoxic systemic treatments.
• To provide an overview for understanding angiosarcoma biology and therapeutic strategies.

Main Methods:

• Literature review of pre-clinical and clinical studies on angiosarcomas.
• Analysis of oncogenic and angiogenesis-related pathways.
• Examination of immunological features and responses to checkpoint inhibitors.

Main Results:

• Angiosarcomas exhibit complex and heterogeneous molecular landscapes.
• Specific oncogenic and angiogenesis pathways are implicated but require further validation.
• Limited but promising responses to checkpoint inhibitors suggest a role for immunotherapy.

Conclusions:

• Understanding critical biological pathways is essential for angiosarcoma treatment.
• Novel non-cytotoxic systemic therapies targeting these pathways show promise.
• Further elucidation of immunological features is needed for effective immunotherapy.